CS182793B2 - Method for production of substituted ce-pentanorprostaglandins - Google Patents

Method for production of substituted ce-pentanorprostaglandins

Info

Publication number
CS182793B2
CS182793B2 CS7500006065A CS606573A CS182793B2 CS 182793 B2 CS182793 B2 CS 182793B2 CS 7500006065 A CS7500006065 A CS 7500006065A CS 606573 A CS606573 A CS 606573A CS 182793 B2 CS182793 B2 CS 182793B2
Authority
CS
Czechoslovakia
Prior art keywords
pentanorprostaglandins
substituted
production
Prior art date
Application number
CS7500006065A
Other languages
Czech (cs)
English (en)
Inventor
Jasjit S Bindra
Michael R Johnson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of CS182793B2 publication Critical patent/CS182793B2/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5407Acyclic saturated phosphonium compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6524Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CS7500006065A 1972-11-08 1973-11-08 Method for production of substituted ce-pentanorprostaglandins CS182793B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30481372A 1972-11-08 1972-11-08

Publications (1)

Publication Number Publication Date
CS182793B2 true CS182793B2 (en) 1978-05-31

Family

ID=23178133

Family Applications (3)

Application Number Title Priority Date Filing Date
CS7500006065A CS182793B2 (en) 1972-11-08 1973-11-08 Method for production of substituted ce-pentanorprostaglandins
CS7300007669A CS182791B2 (en) 1972-11-08 1973-11-08 Method for production of substituted ce-pentanorprostaglandins
CS7500006066A CS182794B2 (en) 1972-11-08 1973-11-08 Method for production of intermediates for preparating substituted ce-pentanorprostaglandins

Family Applications After (2)

Application Number Title Priority Date Filing Date
CS7300007669A CS182791B2 (en) 1972-11-08 1973-11-08 Method for production of substituted ce-pentanorprostaglandins
CS7500006066A CS182794B2 (en) 1972-11-08 1973-11-08 Method for production of intermediates for preparating substituted ce-pentanorprostaglandins

Country Status (29)

Country Link
JP (3) JPS5416491B2 (es)
AR (3) AR200585A1 (es)
AT (3) AT367034B (es)
AU (1) AU470375B2 (es)
BE (1) BE806995A (es)
CA (3) CA1085831A (es)
CH (1) CH597176A5 (es)
CS (3) CS182793B2 (es)
DD (4) DD118856A5 (es)
DE (1) DE2355540C2 (es)
DK (1) DK144247C (es)
ES (3) ES420325A1 (es)
FI (1) FI60389C (es)
FR (3) FR2205335B1 (es)
GB (3) GB1456514A (es)
HK (3) HK27979A (es)
HU (3) HU171819B (es)
IE (1) IE39537B1 (es)
IL (1) IL43589A (es)
IN (1) IN139384B (es)
KE (3) KE2932A (es)
MY (3) MY7900243A (es)
NL (1) NL164273C (es)
NO (3) NO147836C (es)
PH (3) PH13272A (es)
SE (4) SE448992B (es)
SU (4) SU584766A3 (es)
YU (3) YU39715B (es)
ZA (1) ZA738554B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3929862A (en) * 1974-01-08 1975-12-30 Upjohn Co Substituted tolylesters of PGF{HD 2{B {60
US3986764A (en) * 1975-03-31 1976-10-19 Gte Automatic Electric Laboratories Incorporated Panel for supporting a pair of elongated mating connectors and selectively locking them together
GB1506816A (en) * 1975-03-31 1978-04-12 Upjohn Co Prostaglandins
ES449162A1 (es) * 1975-06-23 1977-12-16 Syntex Inc Un procedimiento para la preparacion de un compuesto racemi-co u 8r-antimerico.
GB1516414A (en) * 1975-08-22 1978-07-05 Ici Ltd Prostane derivatives
SE7809008L (sv) * 1977-12-12 1979-06-13 Upjohn Co Anvendning av amider av prostaglandintyp for att styra eller reglera reproduktionscykeln hos individer tillhorande deggdjursarter
DK523378A (da) * 1978-01-16 1979-07-17 Pfizer Fremgangsmaade til fremstilling af n-(tetrazol-5-yl) prostaglandin-carboxamider eller salte deraf
WO1999012898A1 (en) * 1997-09-09 1999-03-18 The Procter & Gamble Company Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists
EP1159266B1 (en) 1999-03-05 2004-11-03 Duke University C-16 unsaturated fp-selective prostaglandins analogs
US6894175B1 (en) 1999-08-04 2005-05-17 The Procter & Gamble Company 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
JP2002329615A (ja) * 2001-05-02 2002-11-15 Ohira Denshi Kk トロイダルコイル
US6476064B1 (en) * 2001-06-13 2002-11-05 Allergan, Inc. Cyclopentane heptan(ene) acyl sulfonamide, 2-alkyl or 2-arylalkyl, or 2-heteroarylalkenyl derivatives as therapeutic agents
WO2006047466A2 (en) 2004-10-21 2006-05-04 Duke University Ophthamological drugs
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8623918B2 (en) 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1324737A (en) * 1970-11-02 1973-07-25 Upjohn Co Prostaglandins and the preparation thereof
IE37602B1 (en) * 1971-05-11 1977-08-31 Ici Ltd Cyclopentane derivatives

Also Published As

Publication number Publication date
PH13325A (en) 1980-03-13
JPS5257147A (en) 1977-05-11
NO148998B (no) 1983-10-17
YU270680A (en) 1983-04-27
KE2931A (en) 1979-03-30
NO750535L (es) 1974-05-09
AR202931A1 (es) 1975-07-31
MY7900243A (en) 1979-12-31
ES420325A1 (es) 1976-04-16
HU173507B (hu) 1979-05-28
SU893130A3 (ru) 1981-12-23
DD109212A5 (es) 1974-10-20
DE2365322B2 (de) 1977-02-24
KE2932A (en) 1979-03-30
AT353285B (de) 1979-11-12
CA1088931A (en) 1980-11-04
NO148998C (no) 1984-01-25
SE7700716L (sv) 1977-01-24
GB1456513A (en) 1976-11-24
YU288073A (en) 1982-02-28
ES433047A1 (es) 1976-11-01
FI60389B (fi) 1981-09-30
SE448992B (sv) 1987-03-30
DK144247C (da) 1982-07-12
DE2355540C2 (de) 1982-11-18
NO147836C (no) 1983-06-22
AT367034B (de) 1982-05-25
AR199966A1 (es) 1974-10-08
AT360672B (de) 1981-01-26
SU667141A3 (ru) 1979-06-05
FR2205335B1 (es) 1978-07-13
AR200585A1 (es) 1974-11-22
DD119411A5 (es) 1976-04-20
FR2283146B1 (es) 1981-06-19
YU270780A (en) 1982-06-18
CS182791B2 (en) 1978-05-31
DK144247B (da) 1982-01-25
ATA544576A (de) 1980-06-15
ATA936973A (de) 1981-10-15
FR2279729B1 (es) 1978-04-28
HK27979A (en) 1979-05-11
IN139384B (es) 1976-06-12
HK28079A (en) 1979-05-11
GB1456512A (en) 1976-11-24
IE39537B1 (en) 1978-11-08
AU470375B2 (en) 1976-03-11
NO149139B (no) 1983-11-14
JPS4993342A (es) 1974-09-05
DD118856A5 (es) 1976-03-20
DD117233A5 (es) 1976-01-05
PH13110A (en) 1979-11-28
SU745362A3 (ru) 1980-06-30
HK28179A (en) 1979-05-11
JPS5253841A (en) 1977-04-30
NO149139C (no) 1984-02-29
ATA544676A (de) 1979-04-15
SE7700718L (sv) 1977-01-24
SU584766A3 (ru) 1977-12-15
HU171819B (hu) 1978-03-28
FR2279729A1 (fr) 1976-02-20
YU37316B (en) 1984-08-31
ES433046A1 (es) 1977-06-16
DE2365322A1 (de) 1974-11-07
PH13272A (en) 1980-02-27
IE39537L (en) 1974-05-08
NL7315263A (es) 1974-05-10
SE431756B (sv) 1984-02-27
FR2283146A1 (fr) 1976-03-26
SE436278B (sv) 1984-11-26
YU36975B (en) 1984-08-31
SE7700717L (sv) 1977-01-24
ZA738554B (en) 1974-09-25
CA1085831A (en) 1980-09-16
JPS5416491B2 (es) 1979-06-22
NO147836B (no) 1983-03-14
KE2930A (en) 1979-03-30
HU172703B (hu) 1978-11-28
CH597176A5 (es) 1978-03-31
IL43589A0 (en) 1974-03-14
IL43589A (en) 1980-01-31
FR2205335A1 (es) 1974-05-31
DE2355540A1 (de) 1974-05-22
AU6224773A (en) 1975-05-08
SE445111B (sv) 1986-06-02
MY7900246A (en) 1979-12-31
NO743493L (no) 1974-05-09
CS182794B2 (en) 1978-05-31
FI60389C (fi) 1982-01-11
NL164273C (nl) 1980-12-15
BE806995A (fr) 1974-05-07
GB1456514A (en) 1976-11-24
MY7900245A (en) 1979-12-31
CA1088930A (en) 1980-11-04
YU39715B (en) 1985-04-30

Similar Documents

Publication Publication Date Title
JPS52142045A (en) Process for manufacture of cyclopropane derivatives
CS187390B2 (en) Method of producing novel derivatives of benzimidazol-2-carbamic acid
CS187389B2 (en) Method of producing alkanolamine derivatives
CS182791B2 (en) Method for production of substituted ce-pentanorprostaglandins
YU3373A (en) Process for obtaining substituted derivatives of piperidinoalkanone-oximes
CS173597B2 (en) Method of 6-aminopenicillic acid production
CS181264B2 (en) Method for production of alpha-amino-alpha-/ureidophenyl/acetamidocephalosporins
CS168033B2 (en) Method of urea production
CS183686B2 (en) Method of producing 1-hydroxy-2-pyridones
CS183721B2 (en) Method of production of alfa-aminoacylcephalosporines
JPS52122349A (en) Process for preparing tntermediate of 155substituteddomegaa pentanoprostagladines
CS182248B2 (en) Method of producing n-benzhydryl-n-p-hydroxy-benzylpiperazine
GB1402501A (en) Process for the production of 4-nitroso-diphenylamine
CS191212B2 (en) Method of producing lysergamides
CS192504B2 (en) Method of producing cyano-methyl-thioacetyl-cephalosporins
EG11021A (en) Process for preparing of new penicillins
YU121973A (en) Process for obtaining silylesters of azetidine-2-sulfenate
EG11062A (en) Process for preparing of new penicillins
BG24661A3 (en) Method of preparing d-1-11-deoxoprostaglandine-e
CS182792B2 (en) Method of production of 2,6-diaminodihydropyridines
CS180570B2 (en) Method for production of erythromycylamines
YU36176B (en) Process for obtaining novel derivatives of aminoimidazoloisoquinoline
CS181238B2 (en) Method of preparing 2-benzoyl-3-aminopyridines
CS193022B2 (en) Method of producing derivatives of phosphonourea or phosphonothiourea
ZA734672B (en) Method for the production of polychromatically active thiazine-eosinates